Clinical Development
Dotmatics Introduces Luma Antibody & Protein Engineering Solution for End-to-End Antibody Discovery
Dotmatics
PR-10-24-NI-57Oct 22, 2024
Clinical Research
TCBP Awarded Non-Dilutive Funding, ScaleReady's G-Rex® Grant
TC Biopharm
PR-10-24-NI-55Oct 22, 2024
Clinical Trail
TALVEY and DARZALEX FASPRO shows deep and durable responses in patients with relapsed or refractory multiple myeloma
Johnson & Johnson
PR-09-24-NI-21Sep 27, 2024